IBB vs SCHX
iShares Biotechnology ETF vs Schwab US Large-Cap ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
SCHX—
Schwab US Large-Cap ETF
Low-cost US large-cap exposure.
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | SCHX |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | Schwab |
IBB top holdings
Holdings data unavailable for IBB.
SCHX top holdings
Holdings data unavailable for SCHX.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About SCHX
SCHX (Schwab US Large-Cap ETF) is Low-cost US large-cap exposure.